Catalyst Pharmaceuticals (CPRX) Capital Expenditures (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.63% |
| Dec 31, 2024 | -66.02% |
| Sep 30, 2024 | 2,490.00% |
| Jun 30, 2024 | -94.97% |
| Mar 31, 2024 | 113.98% |
| Dec 31, 2023 | 45.31% |
| Dec 31, 2021 | -39.71% |
| Sep 30, 2021 | 6,700.00% |
| Jun 30, 2021 | -99.89% |
| Jun 30, 2019 | 143.87% |
| Mar 31, 2019 | -90.09% |
| Dec 31, 2018 | 144.35% |
| Sep 30, 2018 | 94.82% |
| Dec 31, 2016 | 356,400.00% |
| Sep 30, 2015 | 1,176.55% |
| Jun 30, 2015 | -85.71% |
| Mar 31, 2015 | -43.08% |
| Dec 31, 2014 | 5.92% |
| Sep 30, 2014 | 0.90% |
| Jun 30, 2014 | -24.87% |
| Jun 30, 2013 | -100.01% |
| Mar 31, 2013 | -79.27% |
| Dec 31, 2012 | 4,549,900.00% |
| Sep 30, 2012 | -99.95% |
| Jun 30, 2012 | -61.86% |
| Mar 31, 2012 | 173.68% |